Recommandation pour la prise en charge d'une RTU
Traitement de la maladie de Takayasu répondant aux critères d’Ishikawa et résistant aux traitements conventionnels (corticoïdes et immunosuppresseurs
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
BpmPyzGncB52zHvs
Listen
